Bosentan, a selective and more potent antagonist for Atractaspis envenomation than the specific antivenom

Toxicon

Volumn 57, Issue 6, 2011, Pages 861-870

  Abd Elsalam, M A ^a  

^a The National Antivenom and Vaccine Production Center (NAVPC)   (Saudi Arabia)

Author keywords

Antivenom; Atractaspis; Bosentan; Nitroglycerin; Sarafotoxins

Indexed keywords

BOSENTAN; GLYCERYL TRINITRATE; SARAFOTOXIN; SNAKE VENOM ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATRACTASPIS; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; ENVENOMATION; EXPERIMENTAL RABBIT; FEMALE; HEART ARREST; ISOLATED HEART; LETHAL DOSE; MALE; NONHUMAN; OPTIMAL DRUG DOSE; POISONOUS SNAKE; PRIORITY JOURNAL; ST SEGMENT DEPRESSION; STRUCTURAL HOMOLOGY; T WAVE INVERSION; TREATMENT DURATION;

ANIMALS; ANTIVENINS; ELECTROCARDIOGRAPHY; HEART; HUMANS; MALE; NITROGLYCERIN; RABBITS; RECEPTORS, ENDOTHELIN; SNAKE BITES; SNAKES; SULFONAMIDES;

ATRACTASPIS; ORYCTOLAGUS CUNICULUS;

EID: 79954996805     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2011.03.002     Document Type: Article

References (39)

1. Al-Sadoon M.K., Abdo N.M. Fatal envenoming by the snake Atractaspis newly recorded in the central region of Saudi Arabia. J. King Saud Univ. 1991, 3(2):123-131. Science.
2. Bdolah A., Wollberg Z., Kochva E. Snake Toxin-Sarafotoxins: a New Group of Cardiotoxic Peptides from the Venom of Atractaspis 1991, 415. Pergamon Press, New York. A.L. Harvey (Ed.).
3. Bolli R.Z.A., Bhatti X.L., Tang Y.Q., Zhang Y.G., Jadoon A.K. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res. 1997, 81:42-52.
4. Cheng J.W. Bosentan. Heart Dis. 2003, 5(2):161-169.
5. Clozel M., Breu V., Gray G.A., Kalina B., Loffler B.M., Burri K., Cassal J.M., Hirth G., Muller M., Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 1994, 270(1):228-235.
6. Currie B.J. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies. Toxicon 2006, 48(7):941-956.
7. Venomous Snakes of Europe, Northern, Central and Western Asia 2010, Chimaira, Germany. P. David, G. Vogel (Eds.).
8. Ducancel F. The sarafotoxins. Toxicon 2002, 40:1541-1545.
9. Ducancel F. Endothelin-like peptides. Cell. Mol. Life Sci. 2005, 62:2828-2839.
10. Egan D. Snakes of Arabia. A Field Guide to the Snakes of the Arabian Peninsula and Its Shores 2007, Motivate Publishing, Dubai, pp. 1-208.
11. Filep J.G., Fournier A., Foldes-Filep E. Effects of ETA/ETB receptor antagonist, bosentan on endothelin-1-induced myocardial ischemia and oedema in the rat. Br. J. Pharmcol. 1995, 116:1745-1750.
12. Fink G., Li M., Lau Y., Osborn J., Watts S. Chronic activation of endothelin B receptors new model of experimental hypertension. Hypertension 2007, 50:512-518.
13. Gaspertti J. Snakes of Arabia in fauna of Saudi Arabia. National Commission for Wildlife Conservation and Development (NCWCD) Riyadh, Saudi Arabia 1988, vol. 9:282-289. Pro Entomologia c/o National History Museum, Basel, Switzerland. W.F. Buttiker (Ed.).
14. Gupta S.K., Saxena A., Singh U., Arya D.S. Bosentan, the mixed ETa-ETb endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion. Mol. Cell. Biochem. 2005, 275:67-74.
15. Gutierrez J.M., Lomonte B., Leon G., Alape-Giron A., Flores-Diaz M., Sanz L., Angulo Y., Calvete J.J. Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J. Proteomics 2009, 72:165-182.
16. Henry P.J., King S.H. Typical endothelin ETA receptors mediate atypical endothelin-1-induced contractions in sheep isolated tracheal smooth muscle. J. Pharmacol. Exp. Ther. 1999, 89:1385-1390.
17. Hill M., Takano H., Tang T.L., Kodani E., Shirk G., Bolli R. Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerane. Circulation 2001, 104:694-699.
18. Ismail M., Abd-Elsalam M.A., Al-Ahaidib M.S. Pharmacokinetics of 125-I-labelled Walterinnesia aegyptia venom and its specific antivenins: flash absorption and distribution of the venom and its toxin versus slow absorption and distribution of IgG, F(ab')2 and Fab of the antivenin. Toxicon 1998, 36(1):93-114.
19. Ismail M., Al-Ahaidib M.S., Abdoon N., Abd-Elsalam M.A. Preparation of a novel antivenom against Atractaspis and Walterinnesia venoms. Toxicon 2007, 49(1):8-18.
20. Ismail M., Fatani A.J.Y., Dabees T.T. Experimental treatment protocols for scorpion envenomation: a review of common therapies and an effect of kallikrein-kinin inhibitors. Toxicon 1992, 30:1257-1279.
21. Ismail M., Osman O.H., Petkovic D. Electrocardiographic studies with scorpion (Buthus minax L. Koch) venom. Toxicon 1975, 14:79-83.
22. Kochva E., Bdolah A., Wollberg Z. Sarafotoxins and endothelins: evolution, structure and function. Toxicon 1993, 31:541-568.
23. Konrad D.A., Oldner M., Wanecek A., Rudehill E., Weitzberg B., Johansson S., Haggmark S., Haney M. Positive inotropic and negative lusitropic effects of endothelin receptor agonism in vivo. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1702-H1709.
24. Lee S.Y., Lee C.Y., Chen Y.M., Kochva E. Coronary vasospasm as the primary cause of death due to the venom of the burrowing asp Atractaspis engaddensis. Toxicon 1986, 25:285-291.
25. Lin W.W., Chen Y.M., Lee S.Y., Nishio H., Kimura T., Sakakibara S., Lee C.Y. Cardiovascular effects of two disulfide analogues of sarafotoxin S6b. Toxicon 1990, 28(8):911-923.
26. Luscher T.F. Endothelin. Key to coronary vasospasm?. Circulation 1991, 83:476-483.
27. Mann G., Gunders A.E. Epidemiology of snake-bites in Israel. Rofe Hamishpaha 1977, 7:82-87. (the family physician), (in Hebrew, with English summary).
28. Marshall J., Johns E.J. Influence of endothelins and sarafotoxins 6c and L-NAME on renal vasoconstriction in the anaesthetized rat. Br. J. Pharmacol. 1999, 128:809-815.
29. Menez A. Immunology of snake toxins. Snake Toxins, International Encyclopedia of Pharmacology and Therapeutics, Section 134, Chapter 2 1991, 35-90. Pergamon press, New York. A.L. Harvey (Ed.).
30. Motte S., McEntee K., Naeije R. Endothelin receptor antagonists. Pharmacol. Ther. 2006, 110(3):386-414.
31. Patocka J., Merka V., Hrdina V., Hrdina R. Endothelins and sarafotoxins: peptides of similar structure and different function. Acta Med. (Hradic Kralove) 2004, 47(3):157-162.
32. Reeder C.S. Nitrate in the management of acute coronary syndromes Available at:, (accessed october 2010). http://www.uptodate.com/contents/nitrates-in-the-management-of-acute-coronary-syndrome.
33. Rocha-Sousa A., Sarvia J., Amaral M., Alves-Faria P., Falcao-Reis F., Leite-Moreira A.F. ETB2 receptor subtiye stimulation relaxes the iris sphincter muscle. Physio. Res. 2009, 58:835-842.
34. Teerlink J.R., Breu V., Sprecher U., Clozel M., Clozel J.-P. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ. Res. 1994, 74:105-114.
35. Wagner P., Townsend E., Barej M., Rodder M., Spawls S. First record of human envenomation by Atractaspis congica Peters, 1877 (Squmata: atractaspididae). Toxicon 2009, 54:268-373.
36. Warrell D.A., Ormerod L.D., McDavidson N. Bites by night adder Causus maculates and the burrowing vipers (genus Atractaspis) in Nigeria. Am. J. Trop. Med. Hyg. 1976, 25:517-529.
37. Guidelines for the Production Control and Regulation of Snake Antivenom Immunoglobulins 2010, WHO, These Guidelines were adopted by the WHO expert committee on biological standardization at its 59th meeting which took place in Geneva from 13 to 17 October 2008 and will be published in the WHO technical report series.
38. Yang C.M., Yo, Ying-Ling, Ong R., Hsieh J.T., Tsao, Hui-Liang Calcium mobilization induced by endothelins and sarafotoxin in cultured canine tracheal smooth muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 1994, 350(1):68-76.
39. Zhang Yi, Oliver J.R., Horowitz J.D. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist. Cardiovasc. Res. 1998, 39:665-673.